Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Gemifloxacin Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101899044B reveals a greener route for Gemifloxacin main ring synthesis, eliminating hazardous reagents like NaH and ensuring reliable supply chain continuity.
Novel patent CN105585518A offers column-free purification for Gemifloxacin intermediates. Enhances supply chain reliability and reduces manufacturing complexity for global buyers.